Learn about cystic fibrosis, a genetic disorder that affects the lungs, pancreas, and other organs, and how to treat and live with this chronic disease.
Site Search
Showing 1 - 3 of 3 results
PTC Therapeutics has discontinued development of ataluren as a potential treatment for people with cystic fibrosis caused by a nonsense mutation. The Cystic Fibrosis Foundation is supporting efforts to pursue treatments for people with CF who have a nonsense, splicing or other rare mutations.
News
|
March 3, 2017
|
3 min read
Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.
News
|
Sept. 29, 2022
|
3 min read